(firstQuint)Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer.

 RAndomized pilot study of supplemental Iscar in combination with Gemcitabine vs.

 Gemcitabine alone as second line treatment for advanced non-small cell lung cancer.

.

 Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer@highlight

To determine if Iscar Quercus improves immune function and quality of life among patients with stage IV non-small cell lung cancer.

